A small percentage of patients taking GLP-1 medications have experienced vision problems, but a direct causal link with the drugs has not been established, according to a recent paper.
A University at Buffalo research program that is investigating what causes some people with multiple sclerosis to experience severe and aggressive disease is beginning to shed light on how their disease differs from those with mild to moderate MS.